What is the recommended dosage and treatment regimen for clindamycin (antibiotic) for a bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clindamycin Dosage and Treatment Regimen for Bacterial Infections

For bacterial infections, clindamycin should be dosed at 150-300 mg orally every 6 hours for serious infections, and 300-450 mg orally every 6 hours for more severe infections in adults. 1

Adult Oral Dosing

  • For serious infections: 150-300 mg every 6 hours 1
  • For more severe infections: 300-450 mg every 6 hours 1
  • Clindamycin should be taken with a full glass of water to avoid esophageal irritation 1
  • For skin and soft tissue infections: 300-450 mg three times daily 2
  • For MRSA infections: 300-450 mg four times daily 2
  • Duration of therapy is typically 7 days, depending on clinical response 3, 4
  • For streptococcal infections, treatment should continue for at least 10 days 1

Adult Intravenous Dosing

  • For complicated skin and soft tissue infections: 600 mg IV every 8 hours 2
  • For severe infections: 600-900 mg IV every 6-8 hours 2, 5
  • For non-purulent skin and soft tissue infections: 600-900 mg IV every 6 hours 3
  • For pelvic inflammatory disease: 900 mg IV every 8 hours (typically with gentamicin) 5
  • For serious anaerobic infections: 600 mg IV every 6 hours 6

Pediatric Dosing

  • For children who can swallow capsules: 8-16 mg/kg/day divided into three or four equal doses for serious infections 1
  • For more severe pediatric infections: 16-20 mg/kg/day divided into three or four equal doses 1
  • For MRSA infections: 10-13 mg/kg/dose every 6-8 hours (not to exceed 40 mg/kg/day) 5
  • For parenteral administration: 25-40 mg/kg/day in 3 divided doses 3
  • Clindamycin should be dosed based on total body weight regardless of obesity 1

Indication-Specific Considerations

Skin and Soft Tissue Infections

  • For purulent cellulitis: 300-450 mg PO three times daily 2
  • For complicated infections: 600 mg IV/PO three times daily 2
  • For non-purulent cellulitis with systemic signs: 600 mg IV every 8 hours 3

Bone and Joint Infections

  • For osteomyelitis: 600 mg IV/PO three times daily 2
  • Treatment duration for osteomyelitis should be at least 8 weeks 2
  • Some experts recommend adding rifampin for bone infections after clearance of bacteremia 2

Dental Infections

  • 300-450 mg orally every 6-8 hours for 7 days 4
  • For severe dental infections with systemic symptoms, initial parenteral therapy (600-900 mg IV every 8 hours) may be appropriate 4

Important Clinical Considerations

  • Clindamycin is effective against anaerobic bacteria and gram-positive cocci, including MRSA 3, 2
  • If significant diarrhea occurs during therapy, clindamycin should be discontinued due to risk of Clostridioides difficile infection 1
  • Almost all patients (98%) may experience some gastrointestinal side effects, with higher doses (600 mg) associated with more severe and prolonged symptoms 7
  • Three common side effects include stomach upset, diarrhea, and stomach pain 7
  • Surgical drainage remains the primary treatment for abscesses, with antibiotics serving as adjunctive therapy 4
  • For mixed infections, clindamycin is often combined with agents active against gram-negative bacteria 2
  • Clindamycin has become a standard treatment (when combined with an aminoglycoside) for pelvic infections 8
  • For anaerobic lung infections, clindamycin (600 mg IV every 6 hours) has shown better efficacy than penicillin, particularly against penicillin-resistant Bacteroides species 6

Transition from IV to Oral Therapy

  • Intravenous therapy should be continued for at least 48 hours after clinical improvement before transitioning to oral therapy 5
  • The total duration of therapy (IV plus oral) typically ranges from 7-14 days depending on the infection type and clinical response 5

References

Guideline

Clindamycin Dosing Guidelines for Adults with Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clindamycin Dosage and Administration for Dental Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clindamycin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clindamycin.

Obstetrics and gynecology clinics of North America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.